DOI:
10.1055/s-00035024
Thrombosis and Haemostasis
LinksClose Window
References
Iturbe-Hernandez T, García de Guadiana Romualdo L, Gil Ortega I. et al.
Dabigatran, the oral anticoagulant of choice at discharge in patients with non-valvular atrial fibrillation and COVID-19 infection: the ANIBAL protocol.
Drugs Context 2020;
DOI: 10.7573/dic.2020-8-3.
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.